Literature DB >> 6407998

Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1.

R B Markham, G B Pier.   

Abstract

We explored the genetic basis for the differing immune responses observed in inbred strains of mice to a high-molecular-weight polysaccharide (PS) from Pseudomonas aeruginosa immunotype 1 (IT-1). Previous studies have shown that C3H mice immunized with this antigen produce only immunotype-specific antibody. BALB/c mice immunized with IT-1 PS produce both anti-IT-1 PS antibody and antibody cross-reactive with PS from P. aeruginosa immunotype 2 (IT-2). In the current study, we observed that, in addition, these two strains differ in their ability to respond to low immunizing doses of IT-1 PS. C3H mice generated a protective antibody response after a 1-microgram immunization, whereas BALB/c mice failed to produce protective antibody after receiving 1 microgram of PS. Both strains generated protective levels of antibody after a 50-micrograms immunization. Genetic analysis of these response patterns indicates that the ability to produce cross-reactive antibody and the ability to respond to a 1-microgram immunization are independently inherited traits. In addition, the responsiveness of C3H mice to a 1-microgram immunization with the production of protective levels of antibody is not linked to the mouse major histocompatibility (H-2) complex, to sex-linked genes, or to a single gene outside the H-2 complex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407998      PMCID: PMC264768          DOI: 10.1128/iai.41.1.232-236.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Infections caused by Pseudomonas species in patients with burns and in other surgical patients.

Authors:  B A Pruitt
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

2.  Mapping the H-2-linked genes governing, respectively, the immune responses to a glutamic acid-alanine-tyrosine copolymer and to limiting doses of ovalbumin.

Authors:  E K Dunham; M E Dorf; D C Shreffler; B Benacerraf
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

3.  Cross-protection by Pseudomonas aeruginosa polysaccharides.

Authors:  G B Pier
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

4.  Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.

Authors:  S C Schimpff; W H Greene; V M Young; P H Wiernik
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.

Authors:  E Neter
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

6.  Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; S Zolyomi; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

7.  Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

8.  The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice.

Authors:  R B Markham; A Nicholson-Weller; G Schiffman; D L Kasper
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

9.  Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies.

Authors: 
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

10.  Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.

Authors:  G B Pier
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

View more
  3 in total

1.  T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Adoptive transfer of resistance to Pseudomonas aeruginosa infection by splenocytes and bone marrow cells from BALB/c mice immunized by Pseudomonas aeruginosa lectin preparations.

Authors:  D Avichezer; N Gilboa-Garber; M Mumcuoglu; S Slavin
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

3.  Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule.

Authors:  K Hatano; J B Goldberg; G B Pier
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.